肽是由两个或两个以上氨基酸通过脱水缩合形成的化合物。最简单的肽由两个氨基酸构成,称为二肽;包含多个氨基酸的肽则被称为多肽。通常情况下,含有50个及以上氨基酸单位的多肽,则归类为蛋白质。肽广泛存在于动物、植物和微生物中,在生物体内的生长发育、细胞分化、大脑活动、肿瘤病变、免疫防御、生殖控制以及抗衰老等方面都扮演着重要角色。
例如,谷胱甘肽是某些酶的重要辅基,参与体内氧化还原反应;多种激素如催产素、加压素、胰高血糖素及促肾上腺皮质激素等,均属于多肽类,通过调节机体代谢发挥作用。下丘脑分泌的激素调节因子也是由多肽构成,控制着其他内分泌腺释放激素的过程。
近年来,在高等动物的大脑中发现了具有镇痛作用的脑啡肽(五肽)。许多抗生素如多粘菌素、短杆菌肽等也是肽类物质,具备强大的抗菌能力。此外,多肽是指通过肽键连接形成的一系列氨基酸单位构成的长链结构。一般而言,含有数十个或更少氨基酸单位的多肽称为肽;而更多氨基酸单位组成的则被称为蛋白质。
在命名时,通常按照从氨基末端(N端)到羧基末端(C端)的顺序书写。如Ser·Gly·Try·Ala·Leu这个五肽由5个氨基酸残基和4个肽键组成,命名为丝氨酰甘氨酰酪氨酰丙氨酰亮氨酸。
肽广泛存在于动植物组织中,并且其中许多具有特殊生物活性的功能性肽统称为生物活性肽。近年来的研究表明,几乎所有重大生命科学理论——包括免疫防御、生殖控制、肿瘤病变和抗衰防老等——均涉及相关的活性肽,这些理论与临床医学实践密切相关,因此生物活性肽在实际应用中也具有重要价值。
生物活性肽种类繁多,例如促肾上腺皮质激素为39肽,催产素为九肽,而两种重要的脑啡肽均为五肽。许多抗菌素也是由肽类物质构成的。生长因子则受控于基因,在细胞发育过程中起到调节和控制作用。表皮生长因子含有50个氨基酸残基,神经生长因子则由118个氨基酸组成。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(2-azanyl-2-oxidanylidene-ethyl)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-naphthalen-2-yl-1-oxidanylidene-propan-2-yl]amino] | 76932-56-4 | C66H83N17O13 |
|
—— | LHRH, N-epsilon-azidobenzoyl-lys(6)- | 78527-81-8 | C66H87N21O14 |
|
—— | 6-Biotinyllysine-gnrh | 84806-41-7 | C69H98N20O15S |
|
—— | L-Cysteinamide, L-arginyl-L-cysteinyl-3-cyclohexyl-L-alanylglycylglycyl-L-arginyl-L-isoleucyl-L-alpha-aspartyl-L-arginyl-L-isoleucyl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-arginyl-, cyclic (2-13)-disulfide | 1175277-92-5 | C69H116N26O15S2 |
|
—— | H-D-Arg-D-Ser-D-Ser-Cys(1)-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys(1)-NH2 | 111863-73-1 | C64H107N25O19S2 |
|
—— | Corazonin | 122984-73-0 | C62H84N18O18 |
|
—— | L-Argininamide, L-arginyl-L-asparaginyl-L-arginyl-L-leucyl-L-isoleucyl-L-prolyl-L-prolyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl- | 115722-25-3 | C74H119N25O14 |
|
—— | Glutamyl-asparaginyl-prolyl-seryl-glutaminyl-phenylalanyl-tyrosyl-glutamyl-arginyl-leucyl-cysteinamide | 93675-09-3 | C60H89N17O19S |
|
—— | Neurotensin, arg(9)- | 63770-62-7 | C78H121N21O20 |
|
—— | LHRH, N-ac-Pro(1)-(4-Cl-phe)(2)-(2-naphthyl-ala)(3,6)- | 82778-57-2 | C73H89ClN14O13 |
|
—— | (D-Mtf6)-LHRH acetate | 82317-97-3 | C65H84F3N17O15 |
|
—— | LHRH, phe(2)-trp(3)-phe(6)- | 63722-14-5 | C65H83N15O13 |
|
—— | Ranamargarin | 132151-82-7 | C70H110N20O22S |
|
—— | (D-Nal(1)(sup 6))-LHRH acetate | 82317-96-2 | C68H87N17O15 |
|
—— | Substance P, prolyl(2)-tryptophan(7,9)- | 80434-86-2 | C74H106N20O13S |
|
—— | Relaxin C-peptide | 115825-92-8 | C75H118N20O24 |
|
—— | Dynorphin (1-12) | 79985-35-6 | C69H114N22O14 |
|
—— | Eblsp | 87468-59-5 | C73H112N20O15S2 |
|
—— | L-Leucinamide, D-arginyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-D-tryptophyl-L-phenylalanyl-D-tryptophyl-L-leucyl- | 91224-37-2 | C75H108N20O13 |
|
—— | (D-Bna(sup 6))-LHRH acetate | 82318-00-1 | C68H86BrN17O15 |
|
—— | LHRH, Tryptophan(7)- | 70920-44-4 | C60H74N18O13 |
|
—— | 7-Phe-acth amide (1-10) | 74873-14-6 | C59H79N17O15S |
|
—— | H-Ser-gly-gln-ser-trp-arg-pro-gln-gly-arg-phe-NH2 | 127122-98-9 | C57H85N21O15 |
|
—— | H-DL-Pyr-DL-His-DL-Trp-DL-Ser-DL-Tyr-Gly-DL-Leu-DL-Trp-DL-Pro-Gly-NH2 | 55068-87-6 | C60H73N15O13 |
|
—— | Drosulfakinin 1 | 117457-90-6 | C56H73N15O16S |
|
—— | (2S)-2-[[(2S)-2-[[(2R,3S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-acetamido-3-[3-[(2,6-dichlorophenyl)methyl]-4-hydroxyphenyl]propanoyl]amino]-3-methylpentanoyl]amino]-4-amino-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-N-[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide | 140842-17-7 | C70H105Cl2N19O16 |
|
—— | Gpt-LHRH | 68059-94-9 | C67H84N16O13 |
|
—— | Dynorphin B | 85006-82-2 | C74H115N21O17 |
|
—— | Apttlsp | 83374-71-4 | C75H107N19O14 |
|
—— | Caerulein, 1-L-aspartic acid-2-L-arginine-5-L-methionine- | 25842-57-3 | C59H79N15O20S3 |
|
—— | LHRH, N-ac-(4-Cl-Phe)(1,2)-phe(3)-arg(6)-alanh2(10)- | 85416-56-4 | C67H90Cl2N16O14 |
|
—— | H-DL-Pyr-DL-Leu-DL-Tyr-DL-Glu-DL-Asn-DL-Lys-DL-Pro-DL-Arg-DL-Arg-DL-Pro-DL-Tyr(3,5-diBr)-DL-xiIle-DL-Leu-OH | 112898-47-2 | C78H119Br2N21O20 |
|
—— | 1-Arg-5-Phe-7,9-Trp-11-Leu-substance P | 96736-12-8 | C79H109N19O12 |
|
—— | Vasoactive intestinal peptide (1-12) | 112160-96-0 | C62H90N18O22 |
|
—— | Glycylglutaminylglutaminylhistidylhistidylleucylglycylglycylalanyllysylglutaminylalanylglycyl-alpha-aspartylvaline | 80755-86-8 | C62H99N23O21 |
|
—— | LHRH, N-ac-ala(1)-(4-Cl-phe)(2)-trp(3,6)- | 81557-54-2 | C67H85ClN16O13 |
|
—— | Epitope 31D | 122289-52-5 | C75H132N26O19S2 |
|
—— | Alytesin | 31078-12-3 | C68H106N22O17S |
|
—— | Ovuplant | 70235-53-9 | C66H86N18O13 |
|
—— | Atrial natriuretic factor (1-16) | 94345-34-3 | C71H122N28O20S |
|
—— | Dafphedyn | 111846-43-6 | C76H124F5N25O14 |
|
—— | His-Ala-Gly-Pro-Ileu-Ala-Pro-Gly-Glu-Met-Arg-Glu-Pro-Arg-Gly | 119400-71-4 | C66H108N24O19S |
|
—— | Aptaa-lhrh | 83539-08-6 | C69H91Cl2N17O14 |
|
—— | H-Pyr-Phe-Ser-Pro-Glu-Asn-Cys-Gln-Gly-Glu-Ser-Gln-Pro-Cys-OH | 99147-84-9 | C62H89N17O25S2 |
|
—— | H-DL-His-DL-His-DL-Leu-Gly-Gly-DL-Ala-DL-Lys-DL-Gln-DL-Ala-Gly-DL-Asp-DL-Val-OH | —— | C50H80N18O16 |
|
—— | Unii-1464LJ22VI | 57292-43-0 | C60H81N15O13 |
|
—— | Ganirelix Acetate | 129311-55-3 | C84H121ClN18O17 |
|
—— | Polymyxin D1 | 10072-50-1 | C50H93N15O15 |
|
—— | dodecapotassium;(2R,4S)-2-[(1R)-2-[[(5S)-5-amino-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-5-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]pentyl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-[[(2R)-2-[(2R,4S)-4-carboxylato-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylacetyl)amino]acetyl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylate | 61990-92-9 | C264H350K12N48O61S12 |
|
—— | Toxin d (Naja melanoleuca reduced) | 37239-94-4 | C276H440N90O93S9 |
|